7 Questions to Ask Before Buying a Video Vitals API

Most telehealth engineering teams approach a vitals integration the way they approach any third-party dependency: read the docs, check the latency numbers, ship a proof of concept. That instinct works for payment gateways and video transport. It fails for clinical measurement. A video visit vital signs API is not a commodity service where any compliant response is a correct response. The output is a number a clinician may act on, which means the wrong procurement question can move an inaccurate reading into a patient chart. The vendors competing for this layer of the stack vary enormously in how they validate, where they process data, and what they will commit to contractually. The questions below are the ones that separate a defensible buy from a costly one.

A 2024 evaluation of remote photoplethysmography "in the wild" using online webcams reported a mean absolute error of 5.50 BPM for heart rate, compared with sub-2 BPM results achievable under controlled conditions. The gap between those two numbers is the entire procurement problem.

Why a video visit vital signs API demands harder due diligence

The technology underneath most contactless vitals products is remote photoplethysmography, or rPPG, which infers pulse and other signals from subtle color changes in facial skin captured by a standard camera. The method is real and improving fast, but its accuracy is conditional. Lighting, motion, skin tone, camera quality, compression, and bandwidth all degrade the signal in ways that a synthetic benchmark will hide. A vendor can quote an impressive number from a lab dataset and still perform poorly inside a real video call running over a congested home connection.

That is what makes a vitals capture API different from ordinary integration work. The contract you sign is, in effect, a statement about clinical reliability under your specific conditions. Your evaluation has to test the claims, not just read them. The following seven questions are structured to surface the answers vendors do not volunteer.

Before the deep dives, here is how the dimensions of a telehealth API evaluation compare in weight and in how easy they are to verify during a trial.

| Evaluation dimension | What to demand | Verifiable in a 30-day trial? | Risk if ignored | | --- | --- | --- | --- | | Accuracy validation | Per-vital MAE, reference device, demographic breakdown | Partially (run your own bench test) | Wrong values reach the chart | | Conditions and bias testing | Skin tone, lighting, motion, bandwidth results | Yes | Inequitable performance, support load | | Uptime and latency | SLA percentage, p95 latency, status history | Yes | Failed captures mid-visit | | Data handling | Processing location, retention, BAA, frame storage | Yes (review contract) | Compliance exposure | | Regulatory posture | Wellness vs clinical positioning, claims in writing | Yes | Liability and labeling problems | | Integration model | SDK vs cloud, FHIR output, web and native support | Yes | Months of rework | | Support and roadmap | Named escalation, response SLA, model update cadence | Partially | Stalled production incidents |

Question 1: How is accuracy validated, and against what reference?

Ask for the mean absolute error for every vital the product claims, the reference device used, and the size and composition of the validation cohort. A number without a reference is marketing. Research published in 2024 by the authors of the phase-shifted rPPG method reported a heart rate MAE of 1.78 BPM on the MMSE-HR dataset but 3.83 BPM on the more challenging V4V dataset, which shows how heavily results depend on the test set. For blood pressure, the relevant benchmark is ISO 81060-2, which requires a mean difference within plus or minus 5 mmHg and a standard deviation no greater than 8 mmHg. If a vendor claims blood pressure, ask directly whether they meet that standard and on whom.

Question 2: How does the API perform across skin tones, lighting, and motion?

rPPG depends on light reflected from skin, so performance is not uniform across the population. A credible vendor will have stratified results. Demand:

• Heart rate MAE broken out by Fitzpatrick skin type
• Performance under low and uneven lighting
• Degradation curves under subject motion
• Behavior at elevated heart rates, where 2024 reporting found accuracy drops sharply

If a vendor cannot produce demographic breakdowns, assume the gaps exist and will surface as support tickets from your most underserved patients.

Question 3: What are the uptime SLA and real-time latency commitments?

A vitals capture API is invoked live, inside a clinical conversation. A timeout is not a retry opportunity, it is a failed measurement in front of a patient. Require a written uptime SLA with a specific percentage, p95 and p99 latency figures, and access to historical status data rather than a marketing claim of high availability. Confirm what happens to a capture that fails midstream and whether partial results are ever returned as if complete.

Question 4: Where is patient data processed and how long is it retained?

This is where contactless vitals API features intersect with compliance. Establish whether video frames are processed on-device or sent to the cloud, where any cloud processing physically occurs, and whether raw frames are ever stored. The strongest posture is on-device inference where no facial video leaves the patient's machine. If frames do travel, you need a Business Associate Agreement, a documented retention window, and deletion guarantees. Treat any vendor that is vague about frame storage as a vendor that stores frames.

Question 5: What is the regulatory and labeling posture?

Many camera-based products are positioned as wellness tools rather than cleared medical devices, and that distinction governs how your clinicians may use the output. Get the positioning in writing. If a vendor implies clinical-grade performance verbally but ships wellness labeling, your organization inherits the gap. Clarify what claims you are permitted to make to your own users downstream.

Question 6: What is the integration model and does it emit standards-based output?

Architecture decided at signing is expensive to reverse later. Confirm whether the product is a client SDK, a cloud API, or both, and which platforms it supports natively versus web. Ask whether it emits FHIR vital sign resources directly or hands you raw values to map yourself. A vitals API procurement that ignores output format usually pays for it in an unplanned mapping project months later.

Question 7: What does support and the model roadmap actually look like?

rPPG models improve continuously, which is an advantage only if updates reach you. Ask for the update cadence, whether model changes can shift your validated accuracy without notice, named escalation contacts, and a production incident response SLA. A vendor that updates silently can invalidate your own clinical sign-off overnight.

Industry Applications

Primary care and urgent video visits

General telehealth platforms use a video visit vital signs API to capture heart rate and respiratory rate during triage, where the value is contextual rather than diagnostic. Here, conditions testing and uptime matter more than blood pressure precision, because the measurement informs a conversation rather than a prescription.

Chronic care and remote monitoring

Programs managing hypertension or cardiovascular conditions place far more weight on per-vital accuracy and ISO alignment, since values may feed longitudinal trends and reimbursement. A 2026 clinical validation of rPPG pulse rate monitoring in cardiovascular disease patients reported an MAE near 1.06 BPM, evidence that controlled clinical settings can reach tight tolerances, but only when the deployment matches the validation conditions.

Pediatric and elderly care

Both populations stress the conditions question hardest: motion in children, lighting and camera quality with older adults. The procurement question that protects these segments is the demographic breakdown, not the headline number.

Current research and evidence

The evidence base is maturing but uneven. A 2024 multimodal study combining rPPG with machine learning reported a heart rate MAE of roughly 3.06 BPM, and a separate non-contact mobile evaluation reported 2.96 BPM, both consistent with the widely cited plus or minus 2 to 5 BPM range for controlled conditions. The same literature is candid about limits: the 2024 webcam-in-the-wild study's 5.50 BPM result and documented accuracy loss at elevated heart rates show that real-world deployment lives at the harder end of the range. The practical takeaway for buyers is that a single quoted MAE tells you almost nothing without the conditions attached to it. ISO 81060-2's plus or minus 5 mmHg and 8 mmHg standard deviation thresholds remain the clearest objective bar for any blood pressure claim.

The future of video vitals API procurement

Expect procurement to professionalize. As more telehealth platforms adopt camera-based vitals, buyers will standardize on stratified accuracy disclosures, on-device processing as a default privacy posture, and FHIR-native output as a baseline rather than a feature. The vendors that win will publish demographic performance the way cloud vendors publish status pages, and contracts will increasingly tie pricing to validated performance under the buyer's own conditions rather than lab benchmarks. The seven questions above are early versions of what will become a standard checklist.

Frequently asked questions

What accuracy should a video visit vital signs API achieve for heart rate?

Under controlled conditions, a mean absolute error in the range of 2 to 5 BPM is typical, with the best methods reaching below 2 BPM. Real-world video calls perform worse, so always ask for results measured under conditions matching your deployment rather than a single lab figure.

Is rPPG-based blood pressure reliable enough to buy?

Blood pressure is the hardest vital for camera-based methods. The benchmark to apply is ISO 81060-2, which requires a mean difference within plus or minus 5 mmHg and a standard deviation under 8 mmHg. Ask whether the vendor meets it and in what population before trusting any blood pressure claim.

Should video frames be processed on-device or in the cloud?

On-device processing is the stronger privacy posture because facial video never leaves the patient's machine. If a vendor processes in the cloud, require a Business Associate Agreement, a defined retention window, and explicit confirmation of whether raw frames are stored.

How long should a vitals API evaluation take?

Most accuracy, uptime, data handling, and integration questions can be verified in a focused 30-day trial that includes your own bench test against a reference device. Support quality and roadmap discipline take longer to judge and are best assessed through reference customers.

Circadify is building in exactly this space, with an rPPG SDK designed to add real-time vitals to a telehealth platform during video visits without patient hardware. Engineering and procurement leads who want to run the seven questions above against a working implementation can review the platform demo and SDK documentation and book a technical scoping call at circadify.com/custom-builds.